Otonomy (OTIC) is the First to Show Potential in Cochlear Synaptopathy PT to $12 at Oppenheimer
Tweet Send to a Friend
Oppenheimer analyst Francois Brisebois raised the price target on Otonomy (NASDAQ: OTIC) to $12.00 (from $11.00) after the company announced ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
